Patents-Review.com
ClassID:

242727 ⎘

Y10S514/964 - CPC Classification

Classification description:

Sub-classes:
Recent Application in this class:
#1
20200054570
2020-02-20

EXTENDED-RELEASE TOPIRAMATE CAPSULES

 #2
20190216799
2019-07-18

Compositions for affecting weight loss

 #3
20190201354
2019-07-04

COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

 #4
20190008799
2019-01-10

COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

 #5
20180055778
2018-03-01

Extended-release topiramate capsules

 #6
20170281565
2017-10-05

Composition for Administering an NMDA Receptor Antagonist to a Subject

 #7
20170007598
2017-01-12

Compositions for affecting weight loss

 #8
20140287037
2014-09-25

Extended-release topiramate capsules

 #9
20120264978
2012-10-18

Composition for administering an NMDA receptor antagonist to a subject

 #10
20120264829
2012-10-18

Method for administering an NMDA receptor antagonist to a subject

 #11
20120070496
2012-03-22

ANTIDEPRESSANT DOSAGE FORM

 #12
20120058182
2012-03-08

Method and composition for administering an NMDA receptor antagonist to a subject

 #13
20120046365
2012-02-23

Method and composition for administering an NMDA receptor antagonist to a subject

 #14
20120045508
2012-02-23

METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

 #15
20120010232
2012-01-12

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #16
20110237546
2011-09-29

Method for treating a mammal by administration of a compound having the ability to release CO

 #17
20110077296
2011-03-31

Method and composition for delivering zinc to the nasal membrane

 #18
20110059169
2011-03-10

Method and Composition for Administering an NMDA Receptor Antagonist to a Subject

 #19
20110033553
2011-02-10

Embolization

 #20
20100266684
2010-10-21

METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

 #21
20100260838
2010-10-14

METHOD AND COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT

 #22
20100260810
2010-10-14

ANTIDEPRESSANT DOSAGE FORM

 #23
20100196478
2010-08-05

Protein matrix materials, devices and methods of making and using thereof

 #24
20100190793
2010-07-29

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #25
20100047342
2010-02-25

Method and composition for administering an NMDA receptor antagonist to a subject

 #26
20090317394
2009-12-24

VASCULAR ENDOTHELIAL GROWTH FACTOR-2

 #27
20090258786
2009-10-15

Controlled release agricultural products and processes for making the same

 #28
20090030117
2009-01-29

Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient

 #29
20080193494
2008-08-14

Antimicrobial solid surface materials containing chitosan-metal complexes

 #30
20080187587
2008-08-07

Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation

 #31
20080161233
2008-07-03

Sustained Release Formulation of a Peptide

 #32
20080124390
2008-05-29

Pharmaceutical compositions containing lithium carbonate

 #33
20080069885
2008-03-20

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

 #34
20080063721
2008-03-13

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

 #35
20070275970
2007-11-29

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #36
20070270450
2007-11-22

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

 #37
20070269514
2007-11-22

Tablet composition with a prolonged release of tamsulosin

 #38
20070265337
2007-11-15

METHOD AND COMPOSITION FOR DELIVERING ZINC TO THE NASAL MEMBRANE

 #39
20070237824
2007-10-11

Sustained-release preparations of quinolone antibiotics

 #40
20070080323
2007-04-12

Compositions of lipids and cationic peptides

 #41
20070071822
2007-03-29

Film coated tablet for improved upper gastrointestinal tract safety

 #42
20070065509
2007-03-22

Method of preparing sustained-release preparations of quinolone antibiotics

 #43
20070009600
2007-01-11

Antidepressant dosage form

 #44
20060246139
2006-11-02

Bioabsorbable pharmaceutical formulation

 #45
20060233890
2006-10-19

Method for treating a mammal by administration of a compound having the ability to release CO

 #46
20060217397
2006-09-28

Sustained release ranolazine formulations

 #47
20060204591
2006-09-14

Treatment of mucosal membranes

 #48
20060204570
2006-09-14

Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof

 #49
20060182810
2006-08-17

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

 #50
20060148900
2006-07-06

Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof

 #51
20060147521
2006-07-06

Sustained release ranolazine formulations

 #52
20060142398
2006-06-29

Method and composition for administering an NMDA receptor antagonist to a subject

 #53
20060142290
2006-06-29

Compositions for affecting weight loss

 #54
20060115533
2006-06-01

Pharmaceutical compositions

 #55
20060099263
2006-05-11

Antidepressant dosage form

 #56
20060083792
2006-04-20

Therapeutic treatments using the direct application of antimicrobial metal compositions

 #57
20060083777
2006-04-20

Treatment of acne

 #58
20060039997
2006-02-23

Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration

 #59
20050271743
2005-12-08

Treatment of inflammatory skin conditions

 #60
20050238717
2005-10-27

Amino acid modulated extended release dosage form

 #61
20050238714
2005-10-27

Anti-fungal composition

 #62
20050208154
2005-09-22

Pharmaceutical compositions containing lithium carbonate

 #63
20050181979
2005-08-18

Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies

 #64
20050180924
2005-08-18

Composition and method for moisturizing nasal tissue

 #65
20050154361
2005-07-14

Antimicrobial solid surface materials containing chitosan-metal complexes

 #66
20050153982
2005-07-14

Sustained release ranolazine formulations

 #67
20050123626
2005-06-09

Method of administering high-dose, oral magnesium for treatment of chronic pain syndromes or erythromelalgia

 #68
20050118243
2005-06-02

Method and composition for delivering zinc to the nasal membrane

 #69
20050107259
2005-05-19

Controlled release agricultural products and processes for making same

 #70
20050101606
2005-05-12

Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino] pyrimidine trihydrochloride as active ingredient

 #71
20050090560
2005-04-28

Control of parasitic mites of honey bees

 #72
20050089576
2005-04-28

Sustained release formulation of a peptide

 #73
20050089540
2005-04-28

Compositions comprising a dispersant and microcapsules containing an active material and a stabilizer

 #74
20050059667
2005-03-17

Sustained release ranolazine formulations

 #75
20050037058
2005-02-17

Method for producing a silver-containing wound care device

 #76
20050031685
2005-02-10

Pharmaceutical composition for controlled release of a beta-lactam antibiotic

 #77
20050025828
2005-02-03

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

 #78
13847042
2014-02-18

Extended-release topiramate capsules